References
- Aggarwal S, Yadav S, Gupta S. 2011. EGFR targeted PLGA nanoparticles using gemcitabine for treatment of pancreatic cancer. J Biomed Nanotechnol. 7:137–138.
- Amselem S, Yogev A, Zawoznik E, Friedman D. 1994. Emulsomes, a novel drug delivery technology. Proc Int Symp Control Rel Bioact Mater. 21:1368–1369.
- Amselem S, Friedman D. 1997. Solid fat nanoemulsions. United States Patent US 5662932.
- Caliceti P, Salmaso S, Semenzato A, Bersani S, Matricardi P, Rossi F. 2003. Synthesis and physicochemical characterization of folate- cyclodextrin bioconjugate for active drug delivery. Bioconjug Chem. 14:899–908.
- Fumoleau P, Seidman AD, Trudeau ME, Chevallier B, Ten BHWW. 1997. Docetaxel: a new active agent in the therapy of metastatic breast cancer. Expert Opin Investig Drugs. 6:1853–1865.
- Fry DW, White JC, Goldman ID. 1978. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 90:809–815.
- Gupta S, Dube A, Vyas SP. 2007. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis. J Drug Target. 15:437–444.
- Gupta S, Vyas SP. 2007. Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting. J Drug Target. 15:206–217.
- Guo W, Lee T, Sudimack J, Lee RJ. 2000. Receptor-specific delivery of liposomes via folate-peg-chol. J Liposome Res. 10:179–195.
- Lu Y, Low PS. 2002. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev. 54:675–693.
- Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. 2000. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Contr Release. 65:271–284.
- Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
- New RRC. 1990. Introduction and preparation of liposomes. In: New RRC, Ed. Liposomes: A Practical Approach. Oxford: IRL Press, pp. 1–104.
- Pal A, Gupta S, Jaiswal A, Dube A, Vyas SP. 2012. Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J Liposome Res, 22:62–71.
- Rojo F, Albanell J, Rovira A, Corominas JM, Manzarbeitia F. 2008. Targeted therapies in breast cancer. Semin Diagn Pathol. 25: 245–261.
- Saul JM, Annapragada A, Natarajan JV, Bellamkonda RV. 2003. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release. 92:49–67.
- Vyas SP, Katare YK, Mishra V, Sihorkar V. 2000. Ligand directed macrophage targeting of amphotericin B loaded liposomes. Int J Pharm. 210:1–14.
- Vyas SP, Quraishi S, Gupta S, Jaganathan KS. 2005. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm. 296:12–25.
- Vyas SP, Subhedar R, Jain S. 2006. Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver. J Pharm Pharmacol. 58:321–326.
- Vyas SP, Sihorkar V, Jain S. 2007. Mannosylated liposomes for Bio-film targeting. Int J Pharm. 330:6–13.
- Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. 2008. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm. 356:29–36.
- Yuan Z, Chen D, Zhang S, Zheng Z. 2010. Preparation, characterization and evaluation of docetexal-loaded, folate conjugated PEG- liposomes. Yakugaku Zasshi. 130:1353–1359.